Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes

Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes

US Patent 9115357 · Granted Aug 25, 2015

Estimated economic value: $33,550,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of systemic inflammatory responses2024
Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoi2021
Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoi2019
Particle formulations of all-trans retinoic acid and transforming growth factor 2018
Treatment of diseases and conditions caused by increased vascular permeability2018
Interproximal drug delivery device2017
Methods and articles for the detection of exposure to polyhydroxyaromatic skin i2017
Microsphere-based delivery and ex vivo manipulation of dendritic cells for autoi2017
Medical device2017
Methods for treating ocular contusion and blunt injury and traumatic injury to t2017
Methods for treating urushiol-induced contact dermatitis2016
Nucleic acid microspheres, production and delivery thereof2016